UAE: New drug approval to bring hope to breast cancer patients – Khaleej Times


Saturday, May 28, 2022 | Shawwal 26, 1443
Published: Sat 28 May 2022, 2:34 PM
UAE’s Ministry of Health and Prevention has authorized the use of a new drug developed by MSD Pharmaceuticals that is set to bring hope to triple-negative breast cancer (TNBC) patients.
This makes the UAE the world’s second country to approve the drug after the United States.
Breast cancer accounts for 21.4 per cent of the number of new cancer cases in the UAE, according to the World Health Organization data from 2020, with TNBC constituting 15 per cent of total breast cancer cases globally.
“The approval offers a significant sense of hope for patients with this aggressive form of breast cancer as it increases the treatment options,” said Prof Humaid Al Shamsi, President EOS & professor at the University of Sharjah.
“The launch of this new drug will offer a renewed sense of hope for patients with TNBC. They will now have access to this immuno-therapy across public and private clinics,” said Dr Dina Hamza, Consultant Medical Oncologist, Dubai Hospital.
Prof Al Shamsi said that TNBC is aggressive cancer.
“The approved drug is taken along with chemotherapy,” said Prof Al Shamsi. “The recommended dosage of the drug for TNBC is 200 mg every three weeks or 400 mg every six weeks as an intravenous infusion over 30 minutes.”
“It is administered in combination with chemotherapy for neoadjuvant treatment for 24 weeks, and then as a single agent for adjuvant treatment for up to 27 weeks.”
He also affirmed that the reoccurrence rate of TNBC was reduced under the drug when compared with just chemotherapy.
“The addition of the drug to treatment reduces the reoccurrence rate and risk of death,” added Dr Al Shamsi.
ALSO READ:
Dr Hamza said that the drug would speed up patients’ treatment plans, improve their quality of life and offer better outcomes to the UAE’s TNBC patients. “The drug reduces the risk of aggressive cancer reoccurrence after surgery by more than a third.”
Commenting on the approval and UAE’s healthcare advancement, Prof Al Shamsi said: “We are here at an advantage in the UAE as many life-saving drugs are approved very fast where we have access to new innovations of medicines early, that will immensely contribute to the UAE’s vision to be the hub for medical tourism.”
ayaz@khaleejtimes.com
Health
Authority urges public to not get misled by rumours, and follow official guidelines only
Health6 days ago
Health
Authorities have asked health facilities to report any suspected cases
Health1 week ago
Health
Authorities urge healthcare providers to remain vigilant about disease
Health1 week ago
Health
They advise people with weak immune systems to take extra care
Health1 week ago
Health
Expat’s injuries damaged her nerves and blood vessels
Health1 week ago
Health
Turkish patient is first to be brought to Dubai to receive therapy for genetic disorder
Health1 week ago
Health
Residents can also avail free medicines, vouchers for ECG, ultrasound, physiotherapy session and other check ups
Health1 week ago
Health
Robotic system allows the same movement capacity as human wrist but eliminates any tremors, Dr Yasser Ahmad Al Saeedi says
Health1 week ago

source


Leave a Reply

Your email address will not be published.